← Back
$GLUE All transactions

Monte Rosa Therapeutics, Inc.

▼ SELL

$ Value

$9K

Shares

536

Price

$18

Filed

Mar 2

Insider

Name

Dunn Edmund

Title

Principal Accounting Officer

CIK

0001989401

Roles

Officer

Transaction Details

Transaction Date

2026-03-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,693

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.06 to $18.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | This option is fully vested and exercisable.

Filing Info

Accession No.

0001193125-26-085677

Form Type

4

Issuer CIK

0001826457

Dunn Edmund's History

Date Ticker Type Value
2026-03-04 GLUE $2K
2026-03-02 GLUE M $7K
2026-03-02 GLUE $9K
2026-03-02 GLUE M $0
2026-02-27 GLUE M $337K
2026-02-27 GLUE $456K
2026-02-27 GLUE M $0
2026-01-05 GLUE $16K
2025-06-03 GLUE $9K

Other Insiders at GLUE (90d)

Insider Bought Sold Last
Warmuth Markus
President & CEO
$239K 2026-04-14
Janku Filip
Chief Medical Officer
$179K 2026-02-23
Nickson Philip
Chief Business & Legal Officer
$103K 2026-04-09
Dunn Edmund
Principal Accounting Officer
$458K 2026-03-04
Bowen Matthew
Principal Accounting Officer
2026-04-06